Gram staining solution is a core reagent for microbiological identification, composed of a crystal violet primary stain, iodine solution as a mordant, 95% ethanol as a decolorizing agent, and safranin or basic fuchsin as a counterstain. It rapidly distinguishes Gram-positive bacteria (retaining the crystal violet-iodine complex and appearing purple) from Gram-negative bacteria (decolorized and counterstained red) based on differences in bacterial cell wall structure.

Clinical specimen bacterial preliminary screening: Direct smear staining of samples such as sputum, urine, and purulent exudate is performed to rapidly distinguish Gram-positive and Gram-negative bacteria, providing initial guidance for infection diagnosis.

Guiding empirical medication: Staining results can be reported within hours, assisting doctors in preliminarily selecting targeted antibiotics before the susceptibility results are available.

R1: "Infectious diseases" must be translated as infectious diseases.  

The original text: Auxiliary diagnosis of infectious diseases: The presence of G⁻ diplococci in cerebrospinal fluid strongly suggests Neisseria meningitidis, guiding emergency treatment.  

Translation:.

Assessment of specimen quality and infection authenticity: Microscopic examination to observe the presence of white blood cells, determining whether it is an infection or contamination; the presence of multiple mixed bacteria suggests mixed infection or contamination.

Narrowing the scope of strain identification: Combining staining results with colony morphology, the pathogenic bacteria are classified to the genus level, providing direction for subsequent biochemical identification.

Rapid Screening of Sterile Body Fluids: Direct smears and staining of blood, joint fluid, pleural and peritoneal effusions, etc., for rapid detection of bacterial infections.